BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Facile analysis of protein-protein interactions in living cells by enriched visualization of the p-body

  • Choi, Miri (Anticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology) ;
  • Baek, Jiyeon (Anticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology) ;
  • Han, Sang-Bae (College of Pharmacy, Chungbuk National University) ;
  • Cho, Sungchan (Anticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology)
  • Received : 2018.03.09
  • Accepted : 2018.05.25
  • Published : 2018.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Protein-Protein Interactions (PPIs) play essential roles in diverse biological processes and their misregulations are associated with a wide range of diseases. Especially, the growing attention to PPIs as a new class of therapeutic target is increasing the need for an efficient method of cell-based PPI analysis. Thus, we newly developed a robust PPI assay (SeePPI) based on the co-translocation of interacting proteins to the discrete subcellular compartment 'processing body' (p-body) inside living cells, enabling a facile analysis of PPI by the enriched fluorescent signal. The feasibility and strength of SeePPI (${\underline{S}}ignal$ ${\underline{e}}nhancement$ ${\underline{e}}xclusively$ on ${\underline{P}}-body$ for ${\underline{P}}rotein-protein$ ${\underline{I}}nteraction$) assay was firmly demonstrated with FKBP12/FRB interaction induced by rapamycin within seconds in real-time analysis of living cells, indicating its recapitulation of physiological PPI dynamics. In addition, we applied p53/MDM2 interaction and its dissociation by Nutlin-3 to SeePPI assay and further confirmed that SeePPI was quantitative and well reflected the endogenous PPI. Our SeePPI assay will provide another useful tool to achieve an efficient analysis of PPIs and their modulators in cells.

Keywords

References

  1. Fletcher S and Hamilton AD (2007) Protein-protein interaction inhibitors: small molecules from screening techniques. Curr Top Med Chem 7, 922-927 https://doi.org/10.2174/156802607780906735
  2. Gonzalez MW and Kann MG (2012) Chapter 4: Protein interactions and disease. PLoS Comput Biol 8, e1002819 https://doi.org/10.1371/journal.pcbi.1002819
  3. Wells JA and McClendon CL (2007) Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450, 1001-1009 https://doi.org/10.1038/nature06526
  4. Scott DE, Bayly AR, Abell C and Skidmore J (2016) Small molecules, big targets: drug discovery faces the protein-protein interaction challenge. Nat Rev Drug Discov 15, 533-550 https://doi.org/10.1038/nrd.2016.29
  5. Jares-Erijman EA and Jovin TM (2003) FRET imaging. Nat Biotechnol 21, 1387-1395 https://doi.org/10.1038/nbt896
  6. Kerppola TK (2008) Bimolecular fluorescence complementation (BiFC) analysis as a probe of protein interactions in living cells. Annu Rev Biophys 37, 465-487 https://doi.org/10.1146/annurev.biophys.37.032807.125842
  7. Lee KB, Hwang JM, Choi IS et al (2011) Direct monitoring of the inhibition of protein-protein interactions in cells by translocation of PKCdelta fusion proteins. Angew Chem Int Ed Engl 50, 1314-1317 https://doi.org/10.1002/anie.201005333
  8. Lee KH, Lee S, Lee WY, Yang HW and Heo WD (2010) Visualizing dynamic interaction between calmodulin and calmodulin-related kinases via a monitoring method in live mammalian cells. Proc Natl Acad Sci U S A 107, 3412-3417 https://doi.org/10.1073/pnas.0911262107
  9. Lee S, Ha JS, Lee SG and Kim TK (2012) Inducible biosynthetic nanoscaffolds as recruitment platforms for detecting molecular target interactions inside living cells. J Am Chem Soc 134, 11346-11349 https://doi.org/10.1021/ja303518d
  10. Aizer A, Brody Y, Ler LW, Sonenberg N, Singer RH and Shav-Tal Y (2008) The dynamics of mammalian P body transport, assembly, and disassembly in vivo. Mol Biol Cell 19, 4154-4166 https://doi.org/10.1091/mbc.e08-05-0513
  11. Kedersha N, Stoecklin G, Ayodele M et al (2005) Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J Cell Biol 169, 871-884 https://doi.org/10.1083/jcb.200502088
  12. Marchi S, Patergnani S and Pinton P (2014) The endoplasmic reticulum-mitochondria connection: one touch, multiple functions. Biochim Biophys Acta 1837, 461-469 https://doi.org/10.1016/j.bbabio.2013.10.015
  13. Smith JJ and Aitchison JD (2013) Peroxisomes take shape. Nat Rev Mol Cell Biol 14, 803-817 https://doi.org/10.1038/nrm3700
  14. Zheng D, Ezzeddine N, Chen CY, Zhu W, He X and Shyu AB (2008) Deadenylation is prerequisite for P-body formation and mRNA decay in mammalian cells. J Cell Biol 182, 89-101 https://doi.org/10.1083/jcb.200801196
  15. Franks TM and Lykke-Andersen J (2008) The control of mRNA decapping and P-body formation. Mol Cell 32, 605-615 https://doi.org/10.1016/j.molcel.2008.11.001
  16. DeRose R, Miyamoto T and Inoue T (2013) Manipulating signaling at will: chemically-inducible dimerization (CID) techniques resolve problems in cell biology. Pflugers Arch 465, 409-417 https://doi.org/10.1007/s00424-012-1208-6
  17. Robida AM and Kerppola TK (2009) Bimolecular fluorescence complementation analysis of inducible protein interactions: effects of factors affecting protein folding on fluorescent protein fragment association. J Mol Biol 394, 391-409 https://doi.org/10.1016/j.jmb.2009.08.069
  18. Iwakuma T and Lozano G (2003) MDM2, an introduction. Mol Cancer Res 1, 993-1000
  19. Shangary S and Wang S (2008) Targeting the MDM2-p53 interaction for cancer therapy. Clin Cancer Res 14, 5318-5324 https://doi.org/10.1158/1078-0432.CCR-07-5136
  20. Burgess A, Chia KM, Haupt S, Thomas D, Haupt Y and Lim E (2016) Clinical Overview of MDM2/X-Targeted Therapies. Front Oncol 6, 7
  21. Kulikov R, Winter M and Blattner C (2006) Binding of p53 to the central domain of Mdm2 is regulated by phosphorylation. J Biol Chem 281, 28575-28583 https://doi.org/10.1074/jbc.M513311200
  22. Fry DC, Wartchow C, Graves B et al (2013) Deconstruction of a nutlin: dissecting the binding determinants of a potent protein-protein interaction inhibitor. ACS Med Chem Lett 4, 660-665 https://doi.org/10.1021/ml400062c
  23. Jung S, Choi M, Choi K et al (2017) Inactivation of human DGAT2 by oxidative stress on cysteine residues. PLoS One 12, e0181076 https://doi.org/10.1371/journal.pone.0181076

Cited by

  1. Splicing Modifier Rescues the Disease Phenotypes in an In Vitro Human Spinal Muscular Atrophy Model pp.1557-8534, 2019, https://doi.org/10.1089/scd.2018.0181